Abstract
Effects of a specific neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), which selectively affects dopaminergic structures, on the substantia nigra pars compacta, caudate nucleus, ventrolateral thalamic nucleus, hippocampus, and cerebellar cortex have been studied by electron microscopy in cats. Mass damage of the neuronal somata and axon terminals was observed only among the nigrostriatal neurons up to complete destruction in almost half of units. The majority of remaining neurons demonstrated a varying degree of dystrophic changes, mainly of the hydropic type. Submicroscopic characteristics of damaged nigral neurons indicated the disturbance of permeability of neuronal plasma membranes, disorders of the water-salt metabolism, suppression of mitochondrial functions, and disintegration of structural proteins, etc. However, signs of reparative processes together with destructive ones have been observed in part of the nigral neurons. The former may be indicative of the possibility of structural and functional restoration of intracellular organelles. Participation of the elements of the blood-brain barrier in the mechanism of general MPTP toxicity is discussed.
Similar content being viewed by others
References
M. Ya. Voloshin, E. P. Lukhanina, B. P. Kolomiets, et al., “Inhibition and excitation processes in thalamic motor nuclei neurons of cat in norm and after nigrostriatal dopaminergic system injury produced by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine,”Neirofiziologiya,21, No.5, 620–629 (1980).
J. S. Schneider, A. Yuwiler, and C. H. Markham, “Production of a Parkinson-like syndrome in the cat with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior, histology and biochemistry,”Exp. Neurol.,91, No. 2, 293–307 (1986).
J. S. Schneider and C. H. Markham, “Immunocytochemical localization of monoamine oxidase-B in the cat brain: clues to understanding N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity,”Exp. Neurol.,97, No. 3, 465–481 (1987).
J. S. Schneider and F. J. Denaro, “Astrocytic responses to the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in cat and mouse brain,”J. Neuropathol. Exp. Neurol.,47, No. 4, 452–458 (1988).
J. S. Williams and J. S. Schneider, “MPTP-induced ventral mesencephalic cell loss in the cat,”Neurosci. Lett.,101, No. 3, 258–262 (1989).
E. Rinvik and I. Grofová, “Observation on the fine structure of the substantia nigra in the cat,”Exp. Brain Res.,11, No. 3, 229–248 (1970).
R. C. Schwyn and C. A. Fox, “The primate substantia nigra: a Golgi and electron microscopic study,”J. Hirnförsch.,15, H. 1, 95–126 (1974).
C. J. Wilson, P. M. Groves, and E. Fifková, “Monoaminergic synapses, including dendro-dendritic synapses in the rat substantia nigra,”Exp. Brain Res.,30, No. 2/3, 161–174 (1977).
N. J. Riachi and S. I. Harik, “Strain differences in systemic N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice correlated best with monoamine oxidase activity at the blood-brain barrier,”Life Sci.,42, No. 23, 2359–2363 (1988).
N. J. Riachi, R. A. Behmand, and S. I. Harik, “Correlation of MPTP neurotoxicityin vivo with oxidation of MPTP by the brain and blood-brain barrierin vitro in five rat strains,”Brain Res.,555, No. 1, 19–24 (1991).
J. D. Adams, P. W. Kalivas, and C. A. Miller, “The acute histopathology of MPTP in the mouse CNS,”Brain Res. Bull.,23, No. 1, 1–17 (1989).
W. J. Brooks, M. F. Jarvis, and G. C. Wagner, “Astrocytes as a primary locus for the conversion of MPTP into MPP+,”J. Neural. Transm.,76, No. 1, 1–12 (1989).
N. N. Bogolepov,Brain Ultrastructure during Hypoxia [in Russian], Meditsina, Moscow (1979).
Yu. N. Kvitnitsky-Ryzhov,The Modern Doctrine of Brain Edema and Swelling [in Russian], Zdorovie, Kiev (1988).
C. J. Sun, J. N. Johannessen, W. Gessner, et al., “Neurotoxic damage to the nigrostriatal system in rats following intranigral administration of MPDP+ and MPP+,”J. Neural Transm.,74, No. 2, 75–86 (1988).
J. A. Javitch, R. J. D'Amato, S. M. Strittmatter, and S. H. Snyder, “Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity,”Proc. Natl. Acad. Sci. USA,82, No. 7, 2173–2177 (1985).
Author information
Authors and Affiliations
Additional information
Neirofiziologiya/Neurophysiology, Vol. 25, No. 5, pp 349–354, September–October, 1993.
Rights and permissions
About this article
Cite this article
Burchinskaya, L.F. Ultrastructural correlates in pathology of nigrostriatal neurons after systemic MPTP administration in cats. Neurophysiology 25, 284–292 (1993). https://doi.org/10.1007/BF01054259
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01054259